Devicare continues its expansion in Latin America

by Gemma Escarré,

Devicare, member of CataloniaBio & HealthTech, is moving forward in its international expansion by closing licensing and distribution agreements in Argentina, Uruguay and Peru. Various pharmaceutical companies will introduce the products from the Lit-Control® brand to improve the urinary healthcare of the residents of Latin America. The company had previously announced its entry into Mexico and Colombia.

“These agreements with leading urological pharmaceutical companies confirm our scientific work, our clinical data, as well as the commercial interest in our products” remarks Rosendo Garganta, co-Founder and CEO of the company located at the UAB Research Park.

The company expects to end 2018 with a presence in more than 20 countries.

More information


To comment, please login or create an account